Neueste Storys

Merck Healthcare Germany

Merck KGaA, Darmstadt, Germany, Announces Recipients of Third Annual EUR1 Million 'Grant for Oncology Innovation' Award

Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media - Grant established by Merck KGaA, Darmstadt, Germany, recognizes pioneering research in personalized treatment of solid tumors - Winners selected by internationally renowned oncologists from 405 applications representing 49 countries Merck KGaA, ...

Merck Healthcare Germany

Merck Announces Recipients of Third Annual EUR1 Million 'Grant for Oncology Innovation' Award

Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or UK-based media - Grant established by Merck recognizes pioneering research in personalized treatment of solid tumors - Winners selected by internationally renowned oncologists from 405 applications representing 49 countries Merck, a leading science and technology company, today announced the recipients of ...

Helsinn Healthcare SA

Helsinn Group Introduces Helsinn Investment Fund

Lugano, Switzerland (ots/PRNewswire) - ~ Helsinn Group creates new investment fund in 40th anniversary year ~ ~ The new fund will focus on supporting early-stage investment opportunities in areas of high unmet patient need ~ Helsinn, the Swiss Pharmaceutical Group focused on building quality cancer care, today introduces Helsinn Investment Fund S.A. ("the Fund"), a fund focused on early-stage investment opportunities in ...

SCHOELLER-BLECKMANN OILFIELD EQUIPMENT Aktiengesellschaft

EANS-Adhoc: Schoeller-Bleckmann Oilfield Equipment AG / Preliminary Termination of current Share Buyback Program

issuer: Schoeller-Bleckmann Oilfield Equipment AG Hauptstrasse 2 A-2630 Ternitz phone: 02630/315110 FAX: 02630/315101 mail: sboe@sbo.co.at WWW: http://www.sbo.at sector: Oil & Gas - Upstream activities ISIN: AT0000946652 indexes: WBI, ATX Prime, ATX stockmarkets: official market: Wien language: English ...

Tillotts Pharma AG

Tillotts Pharma AG's Parent Company Zeria Pharmaceutical Receives Approval for Zentacort® 3mg Capsules in Japan

Rheinfelden, Switzerland (ots/PRNewswire) - Zeria Pharmaceutical Co., Ltd. has received the approval for a new drug application for Zentacort 3mg capsules from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the indication of the improvement of Crohn's Disease (CD). Following the acquisition of the ...

immigon portfolioabbau ag

EANS-Adhoc: immigon portfolioabbau ag /immigon portfolioabbau ag starts a buyback programme for supplementary capital notes and publishes Minimum Tender Prices (6 October 2016)

issuer: immigon portfolioabbau ag Peregringasse 2 A-1090 Wien phone: +43 (0)1 313 40-0 mail: info@immigon.com WWW: www.immigon.com sector: Banking ISIN: AT000B056544, AT000B053442, XS0275528627, AT000B060462, AT000B115902 indexes: stockmarkets: free trade: Berlin, Stuttgart, regulated dealing: Luxembourg Stock ...

Renault-Nissan Alliance

Renault-Nissan Alliance Named Official COP22 Passenger Car Partner with Zero-emission Fleet

Casablanca, Morocco (ots/PRNewswire) - - Alliance to provide a fleet of 50 electric vehicles to the Conference of Parties COP22 in Marrakech. - Fleet dedicated to COP22 to include Renault ZOE, Nissan LEAF and e-NV200. - More than 20 accelerated and standard charging stations to be set up in Marrakech. The Renault-Nissan Alliance, world leader in zero-emission ...

Greater Paris University Hospitals (AP-HP), Asia-Pacific Hepatocellular Carcinoma Trials Group (AHCC), National Cance...

Liver Cancer Researchers from AP-HP and Singapore Collaborate on a Prospective Meta-Analysis of Two Studies of Y-90 resin microspheres versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma (HCC)

Paris and Singapore (ots/PRNewswire) - Cancer researchers from Assistance Publique - Hôpitaux de Paris (AP-HP) and The Asia-Pacific Hepatocellular Carcinoma Trials Group (AHCC), National Cancer Centre Singapore (NCCS) and Singapore Clinical Research Institute (SCRI) announced that they will collaborate on a ...

BKW Energie AG

Acquisition of Alpiq's shares in Swissgrid: BKW and SIRESO reach agreement on their share in Swissgrid

Shire Pharmaceuticals Group Plc

Patent Trial and Appeal Board Upholds the Validity of LIALDA® Patent

Lexington, Massachusetts (ots/PRNewswire) - Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Patent & Trademark Office's Patent Trial and Appeal Board (PTAB) has issued their decision upholding the validity of U.S. Patent No. 6,773,720, related to Shire's LIALDA® (mesalamine) product. The petition seeking to institute inter partes review (IPR) was ...

RHI Magnesita

EANS-News: RHI AG / RHI and Magnesita to combine to create a leading refractory company

company: RHI AG Wienerbergstrasse 9 A-1100 Wien phone: +43 (0)50213-6676 FAX: +43 (0)50213-6130 mail: rhi@rhi-ag.com WWW: http://www.rhi-ag.com sector: Refractories ISIN: AT0000676903 indexes: ATX Prime, ATX stockmarkets: official market: Wien language: English ...

RHI Magnesita

EANS-Adhoc: RHI AG / RHI and Magnesita to combine to create a leading refractory company

issuer: RHI AG Wienerbergstrasse 9 A-1100 Wien phone: +43 (0)50213-6676 FAX: +43 (0)50213-6130 mail: rhi@rhi-ag.com WWW: http://www.rhi-ag.com sector: Refractories ISIN: AT0000676903 indexes: ATX Prime, ATX stockmarkets: official market: Wien language: English ...

Spire Technologies

Spire Technologies Inc. (OTC: SPTK) Announces a Memorandum of Understanding to Acquire and Launch Web-Based Student Housing Platform

Vancouver, British Columbia (ots/PRNewswire) - Spire Technologies Inc. ("Spire") (OTC: SPTK) announces an agreement with DormBooker Inc.("DormBooker" or "the Company"), which will see DormBooker's principals, industry veterans, Amyn Diamond Murji ("Murji"), Jeff Zigman ("Zigman"), & Mayur Patil ("Patil"), become ...

Mars One Ventures AG

DGAP-Adhoc: InFin Innovative Finance AG: Contract signed with Mars One

DGAP-Ad-hoc: InFin Innovative Finance AG / Key word(s): Miscellaneous InFin Innovative Finance AG: Contract signed with Mars One 04.10.2016 / 20:08 Correction of an inside information according to Art. 17 MAR. The issuer is solely responsible for the content of this announcement. 508773  04.10.2016  ...

Renault-Nissan Alliance

Catherine Loubier Appointed Renault-Nissan Alliance Communication Global Director

Paris and Yokohama, Japan (ots/PRNewswire) - Effective October 4, 2016 The Renault-Nissan Alliance today announced the appointment of Catherine Loubier as Alliance Communication Global Director effective October 4, 2016. She will be based at Renault's headquarters in Boulogne, France and oversee a global team based at Renault and at Nissan's headquarters in Yokohama, ...

Invent Farma and neuraxpharm

Invent Farma and neuraxpharm Appoint New Group CEO

London (ots/PRNewswire) - Following the acquisitions of Invent Farma and neuraxpharm (the "Group") by funds advised by Apax Partners, Stephan Walz has been appointed Chief Executive Officer. He will assume the newly-created role of Group CEO and will be leading Invent Farma's and neuraxpharm's activities across all markets. Until 2015 Mr Walz was the CEO of Aristo, a Germany-headquartered, multi-country pharmaceutical ...

Mars One Ventures AG

DGAP-Adhoc: InFin Innovative Finance AG: Contract signed with Mars One

DGAP-Ad-hoc: InFin Innovative Finance AG / Key word(s): Miscellaneous InFin Innovative Finance AG: Contract signed with Mars One 03.10.2016 / 18:06 Disclosure of an inside information according to Article 17 MAR. The issuer is solely responsible for the content of this announcement. 508321  03.10.2016  ...

Fürstentum Liechtenstein

ikr: Milestone for the competitiveness of Liechtenstein's financial centre

Vaduz (ots) - On 30 September 2016, the EEA Joint Committee, whose decisions result in the inclusion of new EU law in the EEA Agreement, decided to incorporate the first package of legal acts relating to the European Supervisory Authorities (ESAs). "This is a milestone for the competitiveness of our financial centre, since equal access to the EU single market has now ...

Binder+Co Aktiengesellschaft

EANS-News: Binder+Co Aktiengesellschaft / End of the Binder+Co share exchange process - start of the invalidation declaration procedure 

company: Binder+Co Aktiengesellschaft Grazerstraße 19-25 A-8200 Gleisdorf phone: +43 3112 800-363 FAX: +43 3112 800-320 mail: karl.grabner@binder-co.at WWW: www.binder-co.com sector: Machine Manufacturing ISIN: AT000BINDER3 indexes: mid market stockmarkets: Third Market: Wien language: English ...

Highlight Event and Entertainment AG

EQS-Adhoc: Highlight Event and Entertainment AG resolves strategic, structural, and personnel changes

EQS Group-Ad-hoc: Highlight Event and Entertainment AG / Key word(s): Strategic Company Decision Highlight Event and Entertainment AG resolves strategic, structural, and personnel changes 30.09.2016 / 17:33 Release of an ad hoc announcement pursuant to Art. 53 KR. 508121  30.09.2016  ...

Semperit AG Holding

EANS-News: Semperit AG Holding / Declan Daly terminates board activity with Semperit

company: Semperit AG Holding Modecenterstrasse 22 A-1030 Wien phone: +43 1 79 777-210 FAX: +43 1 79 777-602 WWW: www.semperitgroup.com sector: Synthetics & Plastics ISIN: AT0000785555 indexes: WBI, ATX Prime, ViDX, Prime Market, ATX Global Players stockmarkets: official market: Wien language: English ...

Daiichi Sankyo Europe GmbH

New Analysis Shows Maintained Efficacy and Safety of LIXIANA® (edoxaban) in Patients with Acute VTE Requiring a Reduced Dose Based on Clinical Criteria

Munich (ots/PRNewswire) - Results highlight the benefits of reduced dose edoxaban compared to warfarin in a potentially higher risk venous thromboembolism (VTE) patient population[1] Daiichi Sankyo Europe GmbH (hereafter Daiichi Sankyo) today announced data from a new analysis of the phase 3 Hokusai-VTE study, which ...

Teva Pharmaceutical Industries Ltd.

EU Marketing Authorization Granted for Teva's Aerivio Spiromax® (fluticasone/salmeterol 500/50)

Amsterdam (ots/PRNewswire) - Approval of hybrid high-dose fluticasone/salmeterol maintenance treatment for people living with severe asthma and COPD, delivered via the award-winning Spiromax® inhaler to help patient usability Teva Pharmaceutical Industries Ltd., announced today that it has received EU Marketing Authorization for Aerivio Spiromax® ...

Saxo Bank (Switzerland) SA

Saxo Bank Reports Higher Profits and Client Assets as Diversification Strategy Yields Results

Copenhagen (ots/PRNewswire) - Saxo Bank Group ("The Group") has reported a net profit of DKK 158 million for the first six months of 2016. During the same period, client collateral deposits continued to rise, increasing by DKK 6 billion, compared to H1 2015, to reach a record high of DKK 82 billion. The operating ...